agm

anyone heading to this?

I would be interested to hear some thoughts from those lucky enough to attend.

some questions that might be worth raising:
- Will the directors promote the company again after their performance (read: time served) shares are issued in Jan?
- Is it a conflict for one of our directors to be buying shares in another listed company, that he is the director of, that is the companies major shareholder, while 'potentially' being aware of market sensitive information relating to ONC and thus his purchases in AKR?
- How is BilltoBill performing numbers wise, cash, revenue, etc?
- How is the Bapco payment system progressing?

thanks.